Loading...

Emanual Michael Maverakis

TitleAsst Prof
InstitutionUniversity of California Davis
Address
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. LeValley PJ, Ovadia EM, Bresette CA, Sawicki LA, Maverakis E, Bai S, Kloxin AM. Design of functionalized cyclic peptides through orthogonal click reactions for cell culture and targeting applications. Chem Commun (Camb). 2018 Jun 04. PMID: 29863200.
      View in: PubMed
    2. Wang EA, Maverakis E. The rapidly evolving lesions of ulcerative pyoderma gangrenosum: a timeline. Int J Dermatol. 2018 May 27. PMID: 29806128.
      View in: PubMed
    3. Maverakis E, Ma C, Shinkai K, Fiorentino D, Callen JP, Wollina U, Marzano AV, Wallach D, Kim K, Schadt C, Ormerod A, Fung MA, Steel A, Patel F, Qin R, Craig F, Williams HC, Powell F, Merleev A, Cheng MY. Diagnostic Criteria of Ulcerative Pyoderma Gangrenosum: A Delphi Consensus of International Experts. JAMA Dermatol. 2018 Apr 01; 154(4):461-466. PMID: 29450466.
      View in: PubMed
    4. Kao J, Wang EA, Cheng MY, Ma C, Kiuru M, Maverakis E. Exuberant scale crust of the scalp. JAAD Case Rep. 2018 May; 4(4):289-291. PMID: 29693050.
      View in: PubMed
    5. Murrell DF, Peña S, Joly P, Marinovic B, Hashimoto T, Diaz LA, Sinha AA, Payne AS, Daneshpazhooh M, Eming R, Jonkman MF, Mimouni D, Borradori L, Kim SC, Yamagami J, Lehman JS, Saleh MA, Culton DA, Czernik A, Zone JJ, Fivenson D, Ujiie H, Wozniak K, Akman-Karakas A, Bernard P, Korman NJ, Caux F, Drenovska K, Prost-Squarcioni C, Vassileva S, Feldman RJ, Cardones AR, Bauer J, Ioannides D, Jedlickova H, Palisson F, Patsatsi A, Uzun S, Yayli S, Zillikens D, Amagai M, Hertl M, Schmidt E, Aoki V, Grando SA, Shimizu H, Baum S, Cianchini G, Feliciani C, Iranzo P, Mascaró JM, Kowalewski C, Hall R, Groves R, Harman KE, Marinkovich MP, Maverakis E, Werth VP. Diagnosis and Management of Pemphigus: recommendations by an International Panel of Experts. J Am Acad Dermatol. 2018 Feb 10. PMID: 29438767.
      View in: PubMed
    6. Dillen CA, Pinsker BL, Marusina AI, Merleev AA, Farber ON, Liu H, Archer NK, Lee DB, Wang Y, Ortines RV, Lee SK, Marchitto MC, Cai SS, Ashbaugh AG, May LS, Holland SM, Freeman AF, Miller LG, Yeaman MR, Simon SI, Milner JD, Maverakis E, Miller LS. Clonally expanded ?d T cells protect against Staphylococcus aureus skin reinfection. J Clin Invest. 2018 Mar 01; 128(3):1026-1042. PMID: 29400698.
      View in: PubMed
    7. Wang EA, Steel A, Luxardi G, Mitra A, Patel F, Cheng MY, Wilken R, Kao J, de Ga K, Sultani H, Merleev AA, Marusina AI, Brassard A, Fung MA, Konia T, Shimoda M, Maverakis E. Classic Ulcerative Pyoderma Gangrenosum Is a T Cell-Mediated Disease Targeting Follicular Adnexal Structures: A Hypothesis Based on Molecular and Clinicopathologic Studies. Front Immunol. 2017; 8:1980. PMID: 29379508.
      View in: PubMed
    8. Ogawa H, Luxardi G, Kirane A, Kulkarni R, Monjazeb AM, Cheng MY, Ma C, Maverakis E. T cells dominate the local immune response induced by intralesional IL-2 in combination with imiquimod and retinoid for in-transit metastatic melanoma. J Invest Dermatol. 2017 Dec 29. PMID: 29291382.
      View in: PubMed
    9. Wang EA, Suzuki E, Maverakis E, Adamopoulos IE. Targeting IL-17 in psoriatic arthritis. Eur J Rheumatol. 2017 Dec; 4(4):272-277. PMID: 29308283.
      View in: PubMed
    10. Kharkar PM, Scott RA, Olney LP, LeValley PJ, Maverakis E, Kiick KL, Kloxin AM. Controlling the Release of Small, Bioactive Proteins via Dual Mechanisms with Therapeutic Potential. Adv Healthc Mater. 2017 Dec; 6(24). PMID: 29024487.
      View in: PubMed
    11. Rehmann MS, Skeens KM, Kharkar PM, Ford EM, Maverakis E, Lee KH, Kloxin AM. Tuning and Predicting Mesh Size and Protein Release from Step Growth Hydrogels. Biomacromolecules. 2017 Oct 09; 18(10):3131-3142. PMID: 28850788.
      View in: PubMed
    12. Zhou F, Shimoda M, Olney L, Lyu Y, Tran K, Jiang G, Nakano K, Davis RR, Tepper CG, Maverakis E, Campbell M, Li Y, Dandekar S, Izumiya Y. Oncolytic Reactivation of KSHV as a Therapeutic Approach for Primary Effusion Lymphoma. Mol Cancer Ther. 2017 Nov; 16(11):2627-2638. PMID: 28847988.
      View in: PubMed
    13. Maverakis E, Wang EA, Shinkai K, Mahasirimongkol S, Margolis DJ, Avigan M, Chung WH, Goldman J, La Grenade L, Pirmohamed M, Shear NH, Tassaeeyakul W, Hoetzenecker W, Klaewsongkram J, Rerkpattanapipat T, Manuyakorn W, Yasuda SU, Sharon VR, Sukhov A, Micheletti R, Struewing J, French LE, Cheng MY. Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Standard Reporting and Evaluation Guidelines: Results of a National Institutes of Health Working Group. JAMA Dermatol. 2017 Jun 01; 153(6):587-592. PMID: 28296986.
      View in: PubMed
    14. Wang EA, Kao J, Cheng MY, Ma C, Dhillon S, Konia T, Maverakis E, Chambers CJ. Severe pellagra masked by concurrent plaque psoriasis: a case report of a hidden diagnosis. Dermatol Online J. 2017 May 15; 23(5). PMID: 28537863.
      View in: PubMed
    15. Patel F, Wilken R, Patel FB, Sultani H, Bustos I, Duong C, Zone JJ, Raychaudhuri SP, Maverakis E. Pathophysiology of Autoimmune Bullous Diseases: Nature Versus Nurture. Indian J Dermatol. 2017 May-Jun; 62(3):262-267. PMID: 28584368.
      View in: PubMed
    16. Bustos-Villalobos I, Bergstrom JW, Haigh NE, Luna JI, Mitra A, Marusina AI, Merleev AA, Wang EA, Sukhov A, Sultani H, Liu R, Bhardwaj G, Guo W, Kung HJ, Lam KS, Maverakis E. ITK inhibition for the targeted treatment of CTCL. J Dermatol Sci. 2017 Jul; 87(1):88-91. PMID: 28434812.
      View in: PubMed
    17. Krishnan S, Shimoda M, Sacchi R, Kailemia MJ, Luxardi G, Kaysen GA, Parikh AN, Ngassam VN, Johansen K, Chertow GM, Grimes B, Smilowitz JT, Maverakis E, Lebrilla CB, Zivkovic AM. HDL Glycoprotein Composition and Site-Specific Glycosylation Differentiates Between Clinical Groups and Affects IL-6 Secretion in Lipopolysaccharide-Stimulated Monocytes. Sci Rep. 2017 Mar 13; 7:43728. PMID: 28287093.
      View in: PubMed
    18. Marusina AI, Ono Y, Merleev AA, Shimoda M, Ogawa H, Wang EA, Kondo K, Olney L, Luxardi G, Miyamura Y, Yilma TD, Villalobos IB, Bergstrom JW, Kronenberg DG, Soulika AM, Adamopoulos IE, Maverakis E. CD4+ virtual memory: Antigen-inexperienced T cells reside in the naïve, regulatory, and memory T cell compartments at similar frequencies, implications for autoimmunity. J Autoimmun. 2017 Feb; 77:76-88. PMID: 27894837.
      View in: PubMed
    19. Raychaudhuri SP, Wilken R, Sukhov AC, Raychaudhuri SK, Maverakis E. Management of psoriatic arthritis: Early diagnosis, monitoring of disease severity and cutting edge therapies. J Autoimmun. 2017 Jan; 76:21-37. PMID: 27836567.
      View in: PubMed
    20. Suzuki E, Maverakis E, Sarin R, Bouchareychas L, Kuchroo VK, Nestle FO, Adamopoulos IE. T Cell-Independent Mechanisms Associated with Neutrophil Extracellular Trap Formation and Selective Autophagy in IL-17A-Mediated Epidermal Hyperplasia. J Immunol. 2016 12 01; 197(11):4403-4412. PMID: 27798153.
      View in: PubMed
    21. Park D, Arabyan N, Williams CC, Song T, Mitra A, Weimer BC, Maverakis E, Lebrilla CB. Salmonella Typhimurium Enzymatically Landscapes the Host Intestinal Epithelial Cell (IEC) Surface Glycome to Increase Invasion. Mol Cell Proteomics. 2016 Dec; 15(12):3653-3664. PMID: 27754876.
      View in: PubMed
    22. Sukhov A, Burrall B, Maverakis E. The history of open access medical publishing: a comprehensive review. Dermatol Online J. 2016 Sep 15; 22(9). PMID: 28329604.
      View in: PubMed
    23. Safra N, Hitchens PL, Maverakis E, Mitra A, Korff C, Johnson E, Kol A, Bannasch MJ, Pedersen NC, Bannasch DL. Serum levels of innate immunity cytokines are elevated in dogs with metaphyseal osteopathy (hypertrophic osteodytrophy) during active disease and remission. Vet Immunol Immunopathol. 2016 Oct 15; 179:32-5. PMID: 27590423.
      View in: PubMed
    24. Sukhov A, Adamopoulos IE, Maverakis E. Interactions of the Immune System with Skin and Bone Tissue in Psoriatic Arthritis: A Comprehensive Review. Clin Rev Allergy Immunol. 2016 Aug; 51(1):87-99. PMID: 26780035.
      View in: PubMed
    25. Cheng MY, Sukhov A, Sultani H, Kim K, Maverakis E. Trends in National Institutes of Health Funding of Principal Investigators in Dermatology Research by Academic Degree and Sex. JAMA Dermatol. 2016 08 01; 152(8):883-8. PMID: 27191545.
      View in: PubMed
    26. Awasthi S, Wilken R, Patel F, German JB, Mills DA, Lebrilla CB, Kim K, Freeman SL, Smilowitz JT, Armstrong AW, Maverakis E. Dietary supplementation with Bifidobacterium longum subsp. infantis (B. infantis) in healthy breastfed infants: study protocol for a randomised controlled trial. Trials. 2016 07 22; 17(1):340. PMID: 27449926; PMCID: PMC4957407.
    27. Petukhova TA, Maverakis E, Ho B, Sharon VR. Urogynecologic complications in Stevens-Johnson syndrome and toxic epidermal necrolysis: Presentation of a case and recommendations for management. JAAD Case Rep. 2016 May; 2(3):202-5. PMID: 27274537; PMCID: PMC4885137.
    28. Leventhal JS, Odell ID, Imaeda S, Maverakis E, King BA. Treatment of melanoma in-transit metastases with combination intralesional interleukin-2, topical imiquimod, and tretinoin 0.1% cream. JAAD Case Rep. 2016 Mar; 2(2):114-6. PMID: 27051847; PMCID: PMC4810288.
    29. Rehmann MS, Luna JI, Maverakis E, Kloxin AM. Tuning microenvironment modulus and biochemical composition promotes human mesenchymal stem cell tenogenic differentiation. J Biomed Mater Res A. 2016 May; 104(5):1162-74. PMID: 26748903.
      View in: PubMed
    30. Wilken R, Fung MA, Shi VY, Cheng MY, Patel F, Sultani H, Maverakis E. Cyclosporine-induced sebaceous hyperplasia in a hematopoetic stem cell transplant patient: delayed onset of a common adverse event. Dermatol Online J. 2016 Jan 15; 22(1). PMID: 26990469.
      View in: PubMed
    31. Kharkar PM, Rehmann MS, Skeens KM, Maverakis E, Kloxin AM. Thiol-ene click hydrogels for therapeutic delivery. ACS Biomater Sci Eng. 2016 Feb 08; 2(2):165-179. PMID: 28361125.
      View in: PubMed
    32. Tran KA, Cheng MY, Mitra A, Ogawa H, Shi VY, Olney LP, Kloxin AM, Maverakis E. MEK inhibitors and their potential in the treatment of advanced melanoma: the advantages of combination therapy. Drug Des Devel Ther. 2016; 10:43-52. PMID: 26730180; PMCID: PMC4694671.
    33. Hong Q, Ruhaak LR, Stroble C, Parker E, Huang J, Maverakis E, Lebrilla CB. A Method for Comprehensive Glycosite-Mapping and Direct Quantitation of Serum Glycoproteins. J Proteome Res. 2015 Dec 04; 14(12):5179-92. PMID: 26510530; PMCID: PMC4670571 [Available on 12/04/16].
    34. Park D, Brune KA, Mitra A, Marusina AI, Maverakis E, Lebrilla CB. Characteristic Changes in Cell Surface Glycosylation Accompany Intestinal Epithelial Cell (IEC) Differentiation: High Mannose Structures Dominate the Cell Surface Glycome of Undifferentiated Enterocytes. Mol Cell Proteomics. 2015 Nov; 14(11):2910-21. PMID: 26355101; PMCID: PMC4638035 [Available on 11/01/16].
    35. Wilken R, Li CS, Sharon VR, Kim K, Patel FB, Patel F, Maverakis E. Topical clobetasol for the treatment of toxic epidermal necrolysis: study protocol for a randomized controlled trial. Trials. 2015 Aug 22; 16:374. PMID: 26297574; PMCID: PMC4546316.
    36. Wilken R, Sharma A, Patel F, Maverakis E. Successful treatment of palmoplantar pustulosis with isotretinoin. Dermatol Online J. 2015 Aug 15; 21(8). PMID: 26437168.
      View in: PubMed
    37. Shi VY, Tran K, Patel F, Leventhal J, Konia T, Fung MA, Wilken R, Garcia MS, Fitzmaurice SD, Joo J, Monjazeb AM, Burrall BA, King B, Martinez S, Christensen SD, Maverakis E. 100% Complete response rate in patients with cutaneous metastatic melanoma treated with intralesional interleukin (IL)-2, imiquimod, and topical retinoid combination therapy: results of a case series. J Am Acad Dermatol. 2015 Oct; 73(4):645-54. PMID: 26259990.
      View in: PubMed
    38. Mitra A, Luna JI, Marusina AI, Merleev A, Kundu-Raychaudhuri S, Fiorentino D, Raychaudhuri SP, Maverakis E. Dual mTOR Inhibition Is Required to Prevent TGF-ß-Mediated Fibrosis: Implications for Scleroderma. J Invest Dermatol. 2015 Nov; 135(11):2873-2876. PMID: 26134944; PMCID: PMC4640976.
    39. He Y, Shimoda M, Ono Y, Villalobos IB, Mitra A, Konia T, Grando SA, Zone JJ, Maverakis E. Persistence of Autoreactive IgA-Secreting B Cells Despite Multiple Immunosuppressive Medications Including Rituximab. JAMA Dermatol. 2015 Jun; 151(6):646-50. PMID: 25901938.
      View in: PubMed
    40. Maverakis E, Cornelius LA, Bowen GM, Phan T, Patel FB, Fitzmaurice S, He Y, Burrall B, Duong C, Kloxin AM, Sultani H, Wilken R, Martinez SR, Patel F. Metastatic melanoma - a review of current and future treatment options. Acta Derm Venereol. 2015 May; 95(5):516-24. PMID: 25520039.
      View in: PubMed
    41. Patel F, Fitzmaurice S, Duong C, He Y, Fergus J, Raychaudhuri SP, Garcia MS, Maverakis E. Effective strategies for the management of pyoderma gangrenosum: a comprehensive review. Acta Derm Venereol. 2015 May; 95(5):525-31. PMID: 25387526.
      View in: PubMed
    42. Armstrong AW, Johnson MA, Lin S, Maverakis E, Fazel N, Liu FT. Patient-centered, direct-access online care for management of atopic dermatitis: a randomized clinical trial. JAMA Dermatol. 2015 Feb; 151(2):154-60. PMID: 25338198.
      View in: PubMed
    43. Maverakis E, Kim K, Shimoda M, Gershwin ME, Patel F, Wilken R, Raychaudhuri S, Ruhaak LR, Lebrilla CB. Glycans in the immune system and The Altered Glycan Theory of Autoimmunity: a critical review. J Autoimmun. 2015 Feb; 57:1-13. PMID: 25578468; PMCID: PMC4340844.
    44. Patel F, Wilken R, Burrall B, Martinez S, Wells V, King B, Maverakis E. Detailed protocol for administration of intralesional IL-2 for the treatment of Stage IIIc and IV M1a metastatic melanoma based on current NCCN guidelines. Dermatol Online J. 2014 Nov 15; 20(11). PMID: 25419744.
      View in: PubMed
    45. Maverakis E, He Y, Patel FB, Fitzmaurice S, Fung MA. Mycobacterium chelonae infection presenting as recurrent cutaneous and subcutaneous nodules--a presentation previously diagnosed as Weber Christian disease. Dermatol Online J. 2014 Jun 15; 20(6). PMID: 24945648.
      View in: PubMed
    46. Sharon V, Burrall B, Patel F, He Y, Konia T, Villalobos IB, Maverakis E. Multimodal therapy of idiopathic pyoderma gangrenosum. Dermatol Online J. 2014 Jun 15; 20(6). PMID: 24945643.
      View in: PubMed
    47. Wu DJ, Dixit N, Suzuki E, Nguyen T, Shin HS, Davis J, Maverakis E, Adamopoulos IE. A novel in vivo gene transfer technique and in vitro cell based assays for the study of bone loss in musculoskeletal disorders. J Vis Exp. 2014 Jun 08; (88). PMID: 24961167; PMCID: PMC4188139.
    48. Adamopoulos IE, Suzuki E, Chao CC, Gorman D, Adda S, Maverakis E, Zarbalis K, Geissler R, Asio A, Blumenschein WM, Mcclanahan T, De Waal Malefyt R, Gershwin ME, Bowman EP. IL-17A gene transfer induces bone loss and epidermal hyperplasia associated with psoriatic arthritis. Ann Rheum Dis. 2015 Jun; 74(6):1284-92. PMID: 24567524; PMCID: PMC4229480.
    49. Maverakis E, Patel F, Kronenberg DG, Chung L, Fiorentino D, Allanore Y, Guiducci S, Hesselstrand R, Hummers LK, Duong C, Kahaleh B, Macgregor A, Matucci-Cerinic M, Wollheim FA, Mayes MD, Gershwin ME. International consensus criteria for the diagnosis of Raynaud's phenomenon. J Autoimmun. 2014 Feb-Mar; 48-49:60-5. PMID: 24491823; PMCID: PMC4018202.
    50. Raychaudhuri SK, Maverakis E, Raychaudhuri SP. Diagnosis and classification of psoriasis. Autoimmun Rev. 2014 Apr-May; 13(4-5):490-5. PMID: 24434359.
      View in: PubMed
    51. Patel F, Marusina AI, Duong C, Adamopoulos IE, Maverakis E. NKG2C, HLA-E and their association with psoriasis. Exp Dermatol. 2013 Dec; 22(12):797-9. PMID: 24279916; PMCID: PMC4939276.
    52. Bouchlaka MN, Sckisel GD, Chen M, Mirsoian A, Zamora AE, Maverakis E, Wilkins DE, Alderson KL, Hsiao HH, Weiss JM, Monjazeb AM, Hesdorffer C, Ferrucci L, Longo DL, Blazar BR, Wiltrout RH, Redelman D, Taub DD, Murphy WJ. Aging predisposes to acute inflammatory induced pathology after tumor immunotherapy. J Exp Med. 2013 Oct 21; 210(11):2223-37. PMID: 24081947.
      View in: PubMed
    53. Shah DR, Yang AD, Maverakis E, Martinez SR. Age-related disparities in use of completion lymphadenectomy for melanoma sentinel lymph node metastasis. J Surg Res. 2013 Nov; 185(1):240-4. PMID: 23809182.
      View in: PubMed
    54. Shah DR, Yang AD, Maverakis E, Martinez SR. Assessing rural-urban disparities in the use of sentinel lymph node biopsy for melanoma. J Surg Res. 2013 Oct; 184(2):1157-60. PMID: 23768765.
      View in: PubMed
    55. Sivamani RK, Goodarzi H, Garcia MS, Raychaudhuri SP, Wehrli LN, Ono Y, Maverakis E. Biologic therapies in the treatment of psoriasis: a comprehensive evidence-based basic science and clinical review and a practical guide to tuberculosis monitoring. Clin Rev Allergy Immunol. 2013 Apr; 44(2):121-40. PMID: 22311162.
      View in: PubMed
    56. He Y, Maverakis E, Ramirez-Maverakis D, Fitzmaurice S. Combination therapy with intralesional triamcinolone and oral dapsone for management of palisaded neutrophilic and granulomatous dermatitis. Dermatol Online J. 2013 Feb 15; 19(2):17. PMID: 23473287.
      View in: PubMed
    57. Martinez SR, Shah DR, Yang AD, Canter RJ, Maverakis E. Sentinel lymph node biopsy in patients with thick primary cutaneous melanoma: patterns of use and underuse utilizing a population-based model. ISRN Dermatol. 2013; 2013:315609. PMID: 23378929; PMCID: PMC3556403.
    58. Bouchlaka MN, Sckisel GD, Wilkins D, Maverakis E, Monjazeb AM, Fung M, Welniak L, Redelman D, Fuchs A, Evrensel CA, Murphy WJ. Mechanical disruption of tumors by iron particles and magnetic field application results in increased anti-tumor immune responses. PLoS One. 2012; 7(10):e48049. PMID: 23133545; PMCID: PMC3485005.
    59. Goodarzi H, Sivamani RK, Garcia MS, Wehrli LN, Craven H, Ono Y, Maverakis E. Effective Strategies for the Management of Pyoderma Gangrenosum. Adv Wound Care (New Rochelle). 2012 Oct; 1(5):194-199. PMID: 24527305.
      View in: PubMed
    60. Sivamani RK, Ma BR, Wehrli LN, Maverakis E. Phytochemicals and Naturally Derived Substances for Wound Healing. Adv Wound Care (New Rochelle). 2012 Oct; 1(5):213-217. PMID: 24527308.
      View in: PubMed
    61. Loh E, Maverakis E, Konia T, Noll E. Lepromatous leprosy in a 26-year-old man with concurrent disseminated tuberculosis. Arch Dermatol. 2012 Sep; 148(9):1096-7. PMID: 22986882.
      View in: PubMed
    62. Guo W, Liu R, Ono Y, Ma AH, Martinez A, Sanchez E, Wang Y, Huang W, Mazloom A, Li J, Ning J, Maverakis E, Lam KS, Kung HJ. Molecular characteristics of CTA056, a novel interleukin-2-inducible T-cell kinase inhibitor that selectively targets malignant T cells and modulates oncomirs. Mol Pharmacol. 2012 Nov; 82(5):938-47. PMID: 22899868; PMCID: PMC3477223.
    63. Martinez SR, Shah DR, Maverakis E, Yang AD. Geographic variation in utilization of sentinel lymph node biopsy for intermediate thickness cutaneous melanoma. J Surg Oncol. 2012 Dec; 106(7):807-10. PMID: 22674455; PMCID: PMC3488127.
    64. Sharon VR, Garcia MS, Bagheri S, Goodarzi H, Yang C, Ono Y, Maverakis E. Management of recalcitrant hidradenitis suppurativa with ustekinumab. Acta Derm Venereol. 2012 May; 92(3):320-1. PMID: 22101775.
      View in: PubMed
    65. Loh E, Fung MA, Maverakis E. Acute guttate psoriasis in a 15-year-old girl with Epstein-Barr virus infection. Arch Dermatol. 2012 May; 148(5):658-9. PMID: 22782168.
      View in: PubMed
    66. Revzin A, Maverakis E, Chang HC. Biosensors for immune cell analysis-A perspective. Biomicrofluidics. 2012 Jun; 6(2):21301-2130113. PMID: 22655003; PMCID: PMC3360707.
    67. Maverakis E, Goodarzi H, Wehrli LN, Ono Y, Garcia MS. The etiology of paraneoplastic autoimmunity. Clin Rev Allergy Immunol. 2012 Apr; 42(2):135-44. PMID: 21246308.
      View in: PubMed
    68. Maverakis E, Li CS, Alikhan A, Lin TC, Idriss N, Armstrong AW. The effect of academic "misrepresentation" on residency match outcomes. Dermatol Online J. 2012 Jan 15; 18(1):1. PMID: 22301038.
      View in: PubMed
    69. Maverakis E. Sercarzian immunology--In memoriam. Eli E. Sercarz, 1934-2009. Cell Immunol. 2012; 273(2):99-108. PMID: 22285103.
      View in: PubMed
    70. Garcia MS, Ono Y, Martinez SR, Chen SL, Goodarzi H, Phan T, Wehrli LN, Miyamura Y, Fung MA, Maverakis E. Complete regression of subcutaneous and cutaneous metastatic melanoma with high-dose intralesional interleukin 2 in combination with topical imiquimod and retinoid cream. Melanoma Res. 2011 Jun; 21(3):235-43. PMID: 21464773.
      View in: PubMed
    71. Zhang W, Ono Y, Miyamura Y, Bowlus CL, Gershwin ME, Maverakis E. T cell clonal expansions detected in patients with primary biliary cirrhosis express CX3CR1. J Autoimmun. 2011 Sep; 37(2):71-8. PMID: 21636249; PMCID: PMC4018194.
    72. He Y, Merin MR, Sharon VR, Maverakis E. Eruptive keloids associated with breast cancer: a paraneoplastic phenomenon? Acta Derm Venereol. 2011 Jun; 91(4):480-1. PMID: 21537824.
      View in: PubMed
    73. Rudolph M, Hebel K, Miyamura Y, Maverakis E, Brunner-Weinzierl MC. Blockade of CTLA-4 decreases the generation of multifunctional memory CD4+ T cells in vivo. J Immunol. 2011 May 15; 186(10):5580-9. PMID: 21478403.
      View in: PubMed
    74. Sivamani RK, Correa G, Ono Y, Bowen MP, Raychaudhuri SP, Maverakis E. Biological therapy of psoriasis. Indian J Dermatol. 2010 Apr-Jun; 55(2):161-70. PMID: 20606887; PMCID: PMC2887522.
    75. Maverakis E, Menezes JS, Ametani A, Han M, Stevens DB, He Y, Wang Y, Ono Y, Miyamura Y, Lam KS, Ward ES, Sercarz EE. Molecular mimics can induce a nonautoaggressive repertoire that preempts induction of autoimmunity. Proc Natl Acad Sci U S A. 2010 Feb 09; 107(6):2550-5. PMID: 20133742; PMCID: PMC2823870.
    76. Takada Y, Ono Y, Saegusa J, Sagusa J, Mitsiades C, Mitsiades N, Tsai J, He Y, Maningding E, Coleman A, Ramirez-Maverakis D, Rodrigues R, Rodriquez R, Takada Y, Maverakis E. A T cell-binding fragment of fibrinogen can prevent autoimmunity. J Autoimmun. 2010 Jun; 34(4):453-9. PMID: 20036106; PMCID: PMC2860040.
    77. Maverakis E, Miyamura Y, Bowen MP, Correa G, Ono Y, Goodarzi H. Light, including ultraviolet. J Autoimmun. 2010 May; 34(3):J247-57. PMID: 20018479; PMCID: PMC2835849.
    78. Chen HY, Fermin A, Vardhana S, Weng IC, Lo KF, Chang EY, Maverakis E, Yang RY, Hsu DK, Dustin ML, Liu FT. Galectin-3 negatively regulates TCR-mediated CD4+ T-cell activation at the immunological synapse. Proc Natl Acad Sci U S A. 2009 Aug 25; 106(34):14496-501. PMID: 19706535; PMCID: PMC2732795.
    79. Maverakis E, Beech JT, Schneider S, Sercarz EE. Presentation of a determinant by MHC class II can be prevented through competitive capture by a flanking determinant on a multideterminant peptide. J Autoimmun. 2008 Aug; 31(1):59-65. PMID: 18375101; PMCID: PMC2770099.
    80. Menezes JS, van den Elzen P, Thornes J, Huffman D, Droin NM, Maverakis E, Sercarz EE. A public T cell clonotype within a heterogeneous autoreactive repertoire is dominant in driving EAE. J Clin Invest. 2007 Aug; 117(8):2176-85. PMID: 17627303; PMCID: PMC1906731.
    81. Maverakis E, Lynch PJ, Fazel N. Acrodermatitis enteropathica. Dermatol Online J. 2007 Jul 13; 13(3):11. PMID: 18328205.
      View in: PubMed
    82. Wadhera A, Maverakis E, Mitsiades N, Lara PN, Fung MA, Lynch PJ. Thymoma-associated multiorgan autoimmunity: a graft-versus-host-like disease. J Am Acad Dermatol. 2007 Oct; 57(4):683-9. PMID: 17433850.
      View in: PubMed
    83. Maverakis E, Fung MA, Lynch PJ, Draznin M, Michael DJ, Ruben B, Fazel N. Acrodermatitis enteropathica and an overview of zinc metabolism. J Am Acad Dermatol. 2007 Jan; 56(1):116-24. PMID: 17190629.
      View in: PubMed
    84. Kwak J, Maverakis E. Epidermolytic hyperkeratosis. Dermatol Online J. 2006 Sep 08; 12(5):6. PMID: 16962021.
      View in: PubMed
    85. van den Elzen P, Menezes JS, Ametani A, Maverakis E, Madakamutil L, Tang XL, Kumar V, Sercarz EE. Limited clonality in autoimmunity: drivers and regulators. Autoimmun Rev. 2004 Nov; 3(7-8):524-9. PMID: 15546801.
      View in: PubMed
    86. Sercarz EE, Maverakis E. Recognition and function in a degenerate immune system. Mol Immunol. 2004 Feb; 40(14-15):1003-8. PMID: 15036903.
      View in: PubMed
    87. Elewaut D, Lawton AP, Nagarajan NA, Maverakis E, Khurana A, Honing S, Benedict CA, Sercarz E, Bakke O, Kronenberg M, Prigozy TI. The adaptor protein AP-3 is required for CD1d-mediated antigen presentation of glycosphingolipids and development of Valpha14i NKT cells. J Exp Med. 2003 Oct 20; 198(8):1133-46. PMID: 14557411; PMCID: PMC2194227.
    88. Robinson WH, Fontoura P, Lee BJ, de Vegvar HE, Tom J, Pedotti R, DiGennaro CD, Mitchell DJ, Fong D, Ho PP, Ruiz PJ, Maverakis E, Stevens DB, Bernard CC, Martin R, Kuchroo VK, van Noort JM, Genain CP, Amor S, Olsson T, Utz PJ, Garren H, Steinman L. Protein microarrays guide tolerizing DNA vaccine treatment of autoimmune encephalomyelitis. Nat Biotechnol. 2003 Sep; 21(9):1033-9. PMID: 12910246.
      View in: PubMed
    89. Sercarz EE, Maverakis E. Mhc-guided processing: binding of large antigen fragments. Nat Rev Immunol. 2003 Aug; 3(8):621-9. PMID: 12974477.
      View in: PubMed
    90. Maverakis E, Beech J, Stevens DB, Ametani A, Brossay L, van den Elzen P, Mendoza R, Thai Q, Macias LH, Ethell D, Campagnoni CW, Campagnoni AT, Sette A, Sercarz EE. Autoreactive T cells can be protected from tolerance induction through competition by flanking determinants for access to class II MHC. Proc Natl Acad Sci U S A. 2003 Apr 29; 100(9):5342-7. PMID: 12707414; PMCID: PMC154347.
    91. Sercarz E, Maverakis E, van den Elzen P, Madakamutil L, Kumar V. Seven surprises in the TCR-centred regulation of immune responsiveness in an autoimmune system. Novartis Found Symp. 2003; 252:165-71; discussion 171-6, 203-10. PMID: 14609218.
      View in: PubMed